MIRA INFORM REPORT

 

 

Report Date :

08.06.2007

 

IDENTIFICATION DETAILS

 

Name :

GLOBAL  MEDICAL  SOLUTIONS  [THAILAND]  CO.,  LTD.

 

 

Registered Office :

1201/81,  1st   Floor,   Sriwara  Town  In  Town, Ladprao  94  [Panjamit]  Road, Wangthonglang,  Bangkok  10310

 

 

Country :

Thailand

 

 

Financials (as on) :

31.12.2005

 

 

Date of Incorporation :

1995

 

 

Com. Reg. No.:

0105538043508

 

 

Legal Form :

Private  Limited  Company

 

 

Line of Business :

Importing,  distributing  and  servicing  of  pharmaceutical  and  medical  solutions  related  to  Radiopharmacy  and  Brachytherapy  products.

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 


name

 

GLOBAL  MEDICAL  SOLUTIONS  [THAILAND]  CO.,  LTD.

 

 

FORMER 

 

SYNCOR  INTERNATIONAL  [THAILAND]  CO.,  LTD.

 

 

SUMMARY

 

BUSINESS  ADDRESS                          :           1201/81,  1st   FLOOR,   SRIWARA  TOWN  IN  TOWN, 

                                                                        LADPRAO  94  [PANJAMIT]  ROAD,                                                                                                                   WANGTHONGLANG,  BANGKOK  10310

TELEPHONE                                         :           [66]  2559-2740-5

FAX                                                      :           [66]  2530-7455

E-MAIL  ADDRESS                                :           synbkk@loxinfo.co.th

REGISTRATION  ADDRESS                  :           SAME  AS  BUSINESS  ADDRESS

 

ESTABLISHED                                     :           1995

REGISTRATION  NO.                           :           0105538043508

CAPITAL REGISTERED                         :           BHT.   3,000,000

CAPITAL PAID-UP                                :           BHT.   3,000,000

FISCAL YEAR CLOSING DATE              :           DECEMBER   31            

LEGAL  STATUS                                  :           PRIVATE  LIMITED  COMPANY

EXECUTIVE                                          :           MR. PRATUENG  KAREKOS,  THAI

                                                                        MANAGING  DIRECTOR           

 

NO.  OF  STAFF                                   :           24

LINES  OF  BUSINESS                          :           MEDICAL  AND  PHARMACEUTICAL  PRODUCTS

                                                                        IMPORTER  AND  DISTRIBUTOR

                                                                         

                                                                         

CORPORATE  PROFILE

 

OPERATING  TREND                            :           STABLE                       

PRESENT  SITUATION                          :           OPERATING  NORMALLY                     

REPUTATION                                       :           GOOD  WITH  NORMAL  BUSINESS  ENGAGEMENT

MANAGEMENT  STANDARD                 :           MANAGEMENT  WITH  FAIR  PERFORMANCE             

 

 

 

 

 

 

 


 

HISTORY

 

The  subject  was  established  on   April  4,  1995  as  a  private  limited  company under  the  registered  name  “Syncor  International  [Thailand]  Co., Ltd.”  by  American  groups,  with  the  business  objective  to  provide  product  and  service  of  medical  solutions  in  Thailand. 

 

On  September  29,  2003,  subject  was  changed  its  name  to  be  GLOBAL  MEDICAL  SOLUTIONS  [THAILAND]  CO.,  LTD.   It  currently  employs  24  staff.  

 

Subject  is  a  wholly  owned  subsidiary  of  HSB  Holding  Corporation  of  U.S.A.

 

The  subject’s  registered  address  is  1201/81  Ladprao  94  Rd.,  Wangthonglang,  Bangkok  10310,   and  this  is  the  subject’s  current  operation  address.  

 

 

THE  BOARD  OF  DIRECTORS

 

     Name

 

Nationality

Age

 

 

 

 

Mrs. Pratueng  Karekos

 

Thai

52

Mr. Haig  Aram  Shahen  Bagerdjiam

 

American

51

Mr. Jay  Richard  Simon

 

American

48

 

 

AUTHORIZED  PERSON

 

One  of  the  above  directors  can  sign  on  behalf  of  the  subject  with  company’s  affixed.

 

 

MANAGEMENT

 

Mrs. Pratueng  Karekos  is  the  Managing  Director.

She  is  Thai  nationality  with  the  age  of  52  years  old.

 

 

BUSINESS  OPERATIONS

 

The  subject  is  engaged  in  importing,  distributing  and  servicing  of  pharmaceutical  and  medical  solutions  related  to  Radiopharmacy  and  Brachytherapy  products.  The  main  products  and  services  are  as  follows:

 

-  Nuclear  Medicine  Products  and  Services

-  Brachytherapy  Products  and  Services

-  PET  Imaging  Products  and  Services

-  Other  Products  and  Services

 

 

IMPORT  

 

100%  of  the  products  is  imported  from  United  States  of  America,  Australia,  Taiwan,  Republic  of  China,  Brazil,  New  Zealand  and  Hong  Kong.


 

MAJOR  SUPPLIERS

 

Global  Medical  Solution  Pty,  Ltd.                    :           Australia

Global  Medical  Solution  Corporation.                :           United  States  of  America

Global  Medical  Solution  [H.K.]  Ltd.                  :           Hong  Kong

Global  Medical  Solution  Taiwan  Ltd.                :           Taiwan

Redpharm  Scientific  Pty.  Ltd.                           :           Australia          

 

 

SALES 

 

100%  of  the  products  is  sold  locally  by  wholesale  to  dealers  and  end-users.

 

 

MAJOR  CUSTOMERS

 

Nuclear  Medicine  and  Radiology  Department

 

 

SUBSIDIARY  AND  AFFILIATED  COMPANY

 

The  subject  is  not  found   to  have  any  subsidiary  nor  affiliated  company  here  in  Thailand.

 

 

LITIGATION

 

Bankruptcy  and  Receivership

 

There  are  no  litigation  on  bankruptcy  and  receivership  cases  filed  against  the  subject  found  at  Legal  Execution  Department  for  the  past  five  years.

 

Others

 

There  are  no  legal  suits  filed  against   the  subject  according  to  IRICO’S  DATABASE  for  the  past  two  years.

 

 

CREDIT  

 

Sales  are  by  cash  or  on  the  credits  term  of  30-60  days.

Imports  are  by  L/C  at  sight  or  T/T.

 

 

BANKING

 

The  Siam  Commercial  Bank  Public  Co.,  Ltd.

 

 

EMPLOYMENT

 

The  subject  employs  24   staff. 

 

 

LOCATION   DETAILS

 

The  premise  is  rented  for  administrative  office  at  the  heading  address.  Premise  is  located  in  commercial/residential   area.

 

 

COMMENT

 

Market of  medical and pharmaceutical has  continued  expanded  by  local consumption.   The significant growth of healthcare business conditions in Thailand showed potential  for the  country to  become  healthcare  and  medical  business  base  in  the  region.  

 

The  subject  still  maintains  its  good  business.

 

 

FINANCIAL  INFORMATION

 

The  capital  was  initially  registered  at  Bht.   2,000,000    divided  into  20,000    shares  of  Bht.  100     each.

 

On  January  31,  2006,  the  capital  was  increased  to  Bht. 3,000,000  divided  into  30,000   shares  of  Bht.  100   each  with  fully  paid.

 

 

THE  SHAREHOLDERS  LISTED  WERE  :  [as  at 

April  30,  2006]

 

       NAME

HOLDING

%

 

 

 

HSB  Holding  Corporation

Nationality:  American

Address    :  Nevada,  U.S.A. 

29,993

100.00

Mrs. Pratueng  Karekos

Nationality:  Thai

Address    :  188/195  Ladprao  84  Rd.,  Wangthonglang, 

                   Bangkok 

         1

-

Mr. Haig  Aram  Shahen  Bagerdjiam

Nationality:  American

Address    :  California,  U.S.A. 

         1

-

Mrs. Esnif  Bagerdjiam

Nationality:  American

Address    :   California,  U.S.A.

         1

-

Mr. Avedis  S.  Bagerdjiam

Nationality:  American

Address    :  California,  U.S.A. 

         1

-

Ms. Marrold  T.  Bagerdjiam

Nationality:  American

Address    :  California,  U.S.A.  

         1

-

Mr. Zae  A.  Bagerdjiam

Nationality:  American

Address    :  California,  U.S.A 

         1

-

Ms. Airpine  Bagerdjiam

Nationality:  American

Address    :  California,  U.S.A

         1

-

 

 

Total  Shareholders 

 

8

 

 

NAME  OF  AUDITOR  &  CERTIFIED  PUBLIC 

ACCOUNTANT  NO.

 

Mr. Itthichote  Rabuetham  No.  5706

 

 


 

BALANCE SHEET [BAHT]

 

 

The  latest  financial figures  published  as  at  December  31,  2005  &  2004  were:

          

ASSETS

                                                                                                

Current Assets

2005

2004

 

 

 

Cash   in   hand  &  at  Bank       [note 1]     

3,566,527.83

1,745,396.73

Trade  Accts.  &  Notes  Receivable   [note 2]

11,882,254.20

10,890,938.06

Inventories                                             

985,349.25

420,486.03

Advance  to  Employees

830,260.00

467,488.50

Goods  Guarantee

-

156,619.00

Other  Current  Assets                  

55,110.54

281,147.42

 

 

 

Total  Current  Assets                

17,319,501.82

14,962,075.74

 

 

 

Fixed Assets                                         [note 3]

5,270,253.75

6,122,971.66

Prepaid  Income  Tax

138,265.89

138,265.89

Other Assets                  

23,833.74

248,243.74

 

Total  Assets                 

 

22,751,855.20

 

20,471,557.03


 

LIABILITIES & SHAREHOLDERS' EQUITY [BAHT]

 

 

Current Liabilities

2005

2004

 

 

 

Trade  Accts.  Payable

7,703,890.40

7,756,691.00

Accrued  Income  Tax

946,600.75

-

Other  Current  Liabilities             

736,353.02

466,504.89

 

 

 

Total Current Liabilities

9,386,844.17

8,223,195.89

 

Long-term  Loan  from  Related  Company

 

12,665,466.46

 

13,291,931.46

 

Total  Liabilities            

 

22,052,310.63

 

21,515,127.35

 

 

 

Shareholders' Equity

 

 

 

 

 

Share  capital : Baht  100  par  value 

  authorized,  issued  and  fully 

  paid  share  capital   20,000  shares

 

 

2,000,000.00

 

 

2,000,000.00

 

 

 

Capital  Paid                      

 2,000,000.00

 2,000,000.00

Unappropriated  [Deficit]                    

[1,300,455.43]

 [3,043,570.32]

 

Total Shareholders' Equity  [Deficit]

 

699,544.57

 

[1,043,570.32]

 

Total Liabilities &  Shareholders'  Equity

 

22,751,855.20

 

20,471,557.03


                                                   

PROFIT  &  LOSS  ACCOUNT

 

 

Revenue

2005

2004

 

 

 

Sales                                         

34,353,731.40

32,596,562.62

Interest  Income              

1,098,765.86

92,324.53

 

Total  Revenues           

 

35,452,497.26

 

32,688,887.15

 

Expenses

 

 

 

 

 

Cost   of   Goods   Sold                           

20,282,634.70

19,144,173.75

Selling  &  Administrative  Expenses

11,769,954.94

11,945,858.32

Loss  on  Exchange  Rate

471,336.08

-

 

Total Expenses             

 

32,523,925.72

 

31,090,032.07

 

 

 

Profit / [Loss] before  Interest  Expenses  &

  Income  Tax

 

2,928,571.54

 

1,598,855.08

Interest  Expenses

-

[138.51]

Income Tax

[1,185,456.65

-

 

Net  Profit / [Loss]

 

1,743,114.89

 

1,598,716.57

 


 

FINANCIAL  NOTE

 

NOTE  1  Cash  in  Hand & at  Bank

 

 

2005

2004

 

 

 

Cash  in  hand

34,594.82

38,180.61

Cash  at  bank

3,531,933.01

1,707,216.12

 

   Total    

 

3,566,527.83

 

1,745,396.73

 

NOTE  2  Trade  Accts. Receivable

 

 

2005

2004

 

 

 

Trade  Accts. Receivable-Related  company

2,640,799.00

2,161,822.56

Trade  Accts. Receivable-Other  company

9,241,455.20

8,729,115.50

 

   Total    

 

11,882,254.20

 

10,890,938.06

 

NOTE  3  :  Fixed  Assets

                                                                                                

 

2005

2004

 

 

 

Building  Improvement

4,511,730.35

4,474,730.35

Hand  Tools  &  Equipment

5,712,471.94

5,712,471.94

Office  Appliances

3,366,930.83

3,177,566.67

Furniture  &  Decoration

1,011,165.25

980,221.32

Vehicles

3,091,124.77

3,119,024.77

  Total

17,693,423.14

17,464,015.05

  Less:  Accumulated  Depreciation

[12,423,169.39]

[11,341,043.39]

 

   Total    

 

5,270,253.75

 

6,122,971.66

 


FINANCIAL  ANALYSIS

 

Annual  Growth  &  Profitability

 

 

Annual  Growth

 

2005

 

2004

 

Net  Sales

 

5.39

 

 

 

Operating  Profit

 

101.77

 

 

 

Net  Profit

 

9.03

 

 

 

Fixed  Assets

 

[13.93]

 

 

 

Total  Assets

 

11.14

 

 

 

Profitability

 

 

 

 

 

Cost  of  Good  Sold

 

59.04

 

58.73

 

Operating  Profit  Margin

 

9.90

 

4.90

 

S  &  A  Expenses

 

34.26

 

36.65

 

Interest Paid

 

0.00

 

0.00

 

Other  Revenues

 

3.20

 

0.28

 

Net  Profit  Margin

 

5.07

 

4.90

 

Earning  Per  Shares

 

87.16

 

79.94

 

No. of  Shares

 

20,000

 

20,000

 

Net  Sales  was  increased  by  5.39%,  Operating  Profit  was  increased  by  101.77%,  Net  Profit  was  increased  by  9.03%,  Fixed  Assets  was  decreased  by  13.93%,  Total  Assets  was  increased  by  11.14%. 


 

 

 

Compare  each  cost  with  sales, Cost  of  Good  Sold  was  increased  from  58.73%  to  59.04%,  Operating  Profit  Margin  was  increased  from  4.90%  to  9.90%,  S  &  A  Expenses  was  decreased  from  36.65%  to  34.26%,  Interest Paid  was  decreased  from  0.00%  to  0.00%,  Other  Revenues  was  increased  from  0.28%  to  3.20%,  Net  Profit  Margin  was  increased  from  4.90%  to  5.07%. 

 

Earning  Per  Shares  was  increased  from  79.94  baht  per  share  to  87.16  baht  per  share.

 

 

 

 

 

 

 

 

 

 

 

 

 

 


 

Liquidity

 

 

Liquidity

 

2005

 

2004

 

Current  Ratio

 

1.85

 

1.82

 

Quick-Assets  Ratio

 

1.65

 

1.66

 

Current  Ratio  was  increased  from  1.82  to  1.85,  show  Current  Assets  can  cover  Current  Liabilities,  Liquidity  Ratio  of  the  company  was   good,  Quick-Assets  Ratio  was  decreased  from  1.66  to  1.65,  capacity  to  pay  Short  Term  Loan  was   good  too,  because  Current  Assets  without  Inventory  can  cover  Current  Liabilities.

 

 

 

 

 

 

 

 

 

 

 

 


 

Leverage

 

 

Leverage

 

2005

 

2004

 

D/E  Ratio

 

31.52

 

[20.62]

 

Times  Interest  Earned

 

0.00

 

11,543.25

 

D/E  Ratio  was  increased  from  -20.62  to  31.52,  show  the  company  had  fund  from  Loan  more  than  fund  from  Equity,  investment  risked  of  the  company  is  high,  Times  Interest  Earned  was  decreased  from  11,543.25  to  0.00,  capacity  to  pay  interest  paid  was  not  good.

 

 

 

 

 

 

 

 

 

 

 

 

 

 


Efficiency

 

 

Efficiency

 

2005

 

2004

 

Fixed  Assets  Turnover

 

6.52

 

5.32

 

Total  Assets  Turnover

 

1.51

 

1.59

 

Return  on  Assets

 

7.66

 

7.81

 

Return  on  Equity

 

249.18

 

153.20

 

Day's  Payable

 

80.73

 

85.67

 

Day’s  Inventories

 

10.33

 

4.64

 

Day’s  Receivables

 

124.52

 

120.28

 

Fixed  Assets  Turnover  was  increased  from  5.32  times  to  6.52  times,  Total  Assets  Turnover  was  decreased  from  1.59  times  to  1.51  times,  show  the  company  could  use  Fixed  Assets  so  efficiently,  Return  on  Assets  was  decreased  from  7.81  to  7.66,  Return  on  Equity  was  increased  from  153.20  to  249.18,  capacity  to  use  Assets  to  make  profit  was   good. 

 

Day's  Payable  was  decreased  from  86  days  to  81  days,  while  Day’s  Inventories  was  increased  from  5  days  to  11  days,  and  Day’s  Receivables  was  increased  from  121  days  to  125  days.

 

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average/normal.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions